An exploratory clinical trial from the University of Pittsburgh has found that low-dose oral lithium may help slow the decline of verbal memory in older adults with mild cognitive impairment.

Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization.

A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.

Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the production of toxic amyloid beta peptides in the first place.

Numerous additional benefits of GLP-1 weight loss drugs continue to be discovered, and new research has found the blockbuster ...

Novo Nordisk slashes U.S. prices for Ozempic and Wegovy by up to 50%, reshaping access to diabetes and weight-loss care.

Memory loss can happen for many reasons, including normal aging, stress, lack of sleep, medication side effects, or medical ...